IGF1R and colorectal cancer: Furthermore, the amount of nuclear IGF-1R serves as an effective predictor of anti-IGF-1R therapy in sarcoma (Asmane et al., 2012) and of drug resistance in liver cancer cells and colorectal cancers (Bodzin et al., 2012; Codony-Servat et al., 2017).